Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,917 | 1,358 | 96.2% |
| Education | $869.94 | 14 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,164 | 183 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,381 | 133 | $0 (2024) |
| Amgen Inc. | $1,865 | 111 | $0 (2024) |
| PFIZER INC. | $1,558 | 112 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,442 | 73 | $0 (2024) |
| Lilly USA, LLC | $1,435 | 106 | $0 (2024) |
| ABBVIE INC. | $1,289 | 95 | $0 (2024) |
| Astellas Pharma US Inc | $1,281 | 40 | $0 (2024) |
| Merck Sharp & Dohme LLC | $962.21 | 71 | $0 (2024) |
| GlaxoSmithKline, LLC. | $697.08 | 51 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,240 | 195 | AstraZeneca Pharmaceuticals LP ($542.61) |
| 2023 | $3,212 | 190 | Lilly USA, LLC ($359.54) |
| 2022 | $2,556 | 155 | Novo Nordisk Inc ($340.28) |
| 2021 | $3,315 | 208 | AbbVie Inc. ($437.70) |
| 2020 | $1,966 | 111 | Novo Nordisk Inc ($310.14) |
| 2019 | $2,995 | 177 | Novo Nordisk Inc ($505.76) |
| 2018 | $3,009 | 188 | Novo Nordisk Inc ($557.68) |
| 2017 | $2,492 | 148 | Novo Nordisk Inc ($562.07) |
All Payment Transactions
1,372 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.23 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: Bone Health | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.04 | General |
| 12/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: UROLOGY | ||||||
| 12/02/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 908 | 1,543 | $280,540 | $130,457 |
| 2022 | 18 | 940 | 1,672 | $262,285 | $129,936 |
| 2021 | 20 | 989 | 1,599 | $244,515 | $121,670 |
| 2020 | 21 | 947 | 1,434 | $210,460 | $97,714 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 330 | $69,990 | $26,534 | 37.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 117 | 317 | $48,055 | $25,234 | 52.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 125 | 145 | $42,275 | $20,296 | 48.0% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 29 | 158 | $39,250 | $14,727 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 97 | 97 | $18,490 | $12,160 | 65.8% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 91 | 106 | $18,800 | $10,658 | 56.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 149 | $21,780 | $8,626 | 39.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 21 | $8,000 | $4,491 | 56.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 54 | 54 | $5,400 | $3,884 | 71.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 67 | 67 | $3,800 | $1,973 | 51.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 19 | 20 | $1,800 | $663.09 | 36.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 16 | $1,680 | $644.80 | 38.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 15 | 18 | $630.00 | $291.60 | 46.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 23 | 25 | $390.00 | $210.00 | 53.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 20 | $200.00 | $65.15 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 339 | $69,495 | $26,880 | 38.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 101 | 270 | $35,100 | $18,628 | 53.1% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 26 | 180 | $36,000 | $17,937 | 49.8% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 101 | 115 | $27,600 | $14,885 | 53.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $15,840 | $12,764 | 80.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 22 | 168 | $21,840 | $11,482 | 52.6% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 79 | 87 | $13,920 | $6,664 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 103 | $14,420 | $6,514 | 45.2% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 64 | 64 | $8,000 | $4,383 | 54.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 12 | $3,900 | $2,634 | 67.5% |
About Vasumathy Kumaresan, M.D,
Vasumathy Kumaresan, M.D, is a Internal Medicine healthcare provider based in Bethlehem, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811000631.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Vasumathy Kumaresan, M.D, has received a total of $22,787 in payments from pharmaceutical and medical device companies, with $3,240 received in 2024. These payments were reported across 1,372 transactions from 75 companies. The most common payment nature is "Food and Beverage" ($21,917).
As a Medicare-enrolled provider, Kumaresan has provided services to 3,784 Medicare beneficiaries, totaling 6,248 services with total Medicare billing of $479,777. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bethlehem, PA
- Active Since 08/16/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811000631
Products in Payments
- Ozempic (Drug) $1,077
- ELIQUIS (Drug) $1,051
- FARXIGA (Drug) $1,016
- JARDIANCE (Drug) $998.42
- VRAYLAR (Drug) $903.76
- Otezla (Drug) $794.08
- Tresiba (Drug) $588.09
- BREZTRI (Drug) $525.60
- REXULTI (Drug) $504.86
- MOUNJARO (Drug) $500.57
- Prolia (Biological) $408.46
- EVENITY (Biological) $379.50
- JANUVIA (Drug) $339.28
- CHANTIX (Drug) $339.23
- XIFAXAN (Drug) $339.13
- NUZYRA (Drug) $312.82
- NURTEC ODT (Drug) $289.96
- SYNJARDY (Drug) $286.52
- SYMBICORT (Drug) $278.84
- TRULICITY (Drug) $277.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bethlehem
Dr. Maria Lamothe, M.d, M.D
Internal Medicine — Payments: $212,477
Mrs. Kerry Lenahan, Crnp, CRNP
Internal Medicine — Payments: $160,101
Aaron Lasker, M.d, M.D
Internal Medicine — Payments: $61,091
Rodrigo Duarte Chavez, Md, MD
Internal Medicine — Payments: $27,654
Mrs. Fatima Ali, D.o, D.O
Internal Medicine — Payments: $21,474
Shivam Saxena
Internal Medicine — Payments: $16,889